Mirum Pharmaceuticals, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Mirum Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -42.3 %, a 59.4% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Return On Equity for 2023 was -88.6 %, a 13.3% increase from 2022.
  • Mirum Pharmaceuticals, Inc. annual Return On Equity for 2022 was -102 %, a 23.6% decline from 2021.
  • Mirum Pharmaceuticals, Inc. annual Return On Equity for 2021 was -82.7 %, a 17.1% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -88.6 +13.6 +13.3% Jan 1, 2023 Dec 31, 2023
2022 -102 -19.5 -23.6% Jan 1, 2022 Dec 31, 2022
2021 -82.7 -12.1 -17.1% Jan 1, 2021 Dec 31, 2021
2020 -70.7 +25.5 +26.5% Jan 1, 2020 Dec 31, 2020
2019 -96.2 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.